• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mixture of blackberry leaf and fruit extracts alleviates non-alcoholic steatosis, enhances intestinal integrity, and increases and in rats.黑莓叶和果实提取物的混合物可减轻大鼠的非酒精性脂肪变性,增强肠道完整性,并增加(此处原文似乎不完整,缺少具体增加的内容)。
Exp Biol Med (Maywood). 2019 Dec;244(18):1629-1641. doi: 10.1177/1535370219889319. Epub 2019 Nov 21.
2
Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.用绞股蓝缓解大鼠非酒精性脂肪肝病过程中肠道微生物群的结构调节。
BMC Complement Med Ther. 2020 Feb 5;20(1):34. doi: 10.1186/s12906-020-2835-7.
3
Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats.瑞士乳杆菌 R0052 通过调节半乳糖胺处理大鼠的肠道微生物组和代谢组缓解肝损伤。
Appl Microbiol Biotechnol. 2019 Dec;103(23-24):9673-9686. doi: 10.1007/s00253-019-10211-8. Epub 2019 Nov 12.
4
Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression.绞股蓝总皂苷可改善非酒精性脂肪肝病小鼠的肠道菌群并缓解其进展。
Biomed Pharmacother. 2019 Oct;118:109258. doi: 10.1016/j.biopha.2019.109258. Epub 2019 Aug 23.
5
Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.参令白术散对高脂饮食诱导的非酒精性脂肪肝大鼠肠道微生物群的影响。
Biomed Pharmacother. 2018 Jun;102:1025-1036. doi: 10.1016/j.biopha.2018.03.158. Epub 2018 Apr 5.
6
Phytotherapy using blueberry leaf polyphenols to alleviate non-alcoholic fatty liver disease through improving mitochondrial function and oxidative defense.利用蓝莓叶多酚进行植物疗法,通过改善线粒体功能和氧化防御来缓解非酒精性脂肪肝疾病。
Phytomedicine. 2020 Apr;69:153209. doi: 10.1016/j.phymed.2020.153209. Epub 2020 Mar 18.
7
The combination of Ilexhainanoside D and ilexsaponin A reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced non-alcoholic fatty liver disease.冬青苷 D 和冬青皂苷 A 的联合作用可减轻高脂饮食诱导的非酒精性脂肪肝病小鼠的肝脏炎症并改善肠道屏障功能。
Phytomedicine. 2019 Oct;63:153039. doi: 10.1016/j.phymed.2019.153039. Epub 2019 Jul 26.
8
Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial.大枣四逆汤治疗非酒精性脂肪性肝病肥胖的随机、双盲、安慰剂对照试验研究方案。
Trials. 2020 Jan 31;21(1):128. doi: 10.1186/s13063-020-4068-y.
9
Artemisia sphaerocephala Krasch polysaccharide prevents hepatic steatosis in high fructose-fed mice associated with changes in the gut microbiota.螺旋蒿多糖可预防高果糖喂养小鼠的肝脂肪变性,其作用可能与肠道微生物群的变化有关。
Food Funct. 2019 Dec 11;10(12):8137-8148. doi: 10.1039/c9fo01890e.
10
Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats.姜黄素介导的肠道微生物群调节可减轻大鼠肝脂肪变性。
Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1801-1812. doi: 10.1016/j.bbagen.2017.03.017. Epub 2017 Mar 21.

引用本文的文献

1
A Systematic Review of the Beneficial Effects of Berry Extracts on Non-Alcoholic Fatty Liver Disease in Animal Models.浆果提取物对动物模型非酒精性脂肪性肝病有益作用的系统评价
Nutr Rev. 2025 May 1;83(5):819-841. doi: 10.1093/nutrit/nuae132.
2
Blackberry-Loaded AgNPs Attenuate Hepatic Ischemia/Reperfusion Injury via PI3K/Akt/mTOR Pathway.负载黑莓的银纳米颗粒通过PI3K/Akt/mTOR信号通路减轻肝脏缺血/再灌注损伤
Metabolites. 2023 Mar 13;13(3):419. doi: 10.3390/metabo13030419.
3
Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders.肠道菌群:中药改善脂质代谢紊乱的新靶点。
Front Pharmacol. 2023 Mar 1;14:1134430. doi: 10.3389/fphar.2023.1134430. eCollection 2023.
4
Anti-Inflammatory and Immunomodulatory Properties of Fermented Plant Foods.发酵植物食品的抗炎和免疫调节特性。
Nutrients. 2021 Apr 30;13(5):1516. doi: 10.3390/nu13051516.
5
Anthocyanins: A Comprehensive Review of Their Chemical Properties and Health Effects on Cardiovascular and Neurodegenerative Diseases.花色苷:化学性质及其对心血管疾病和神经退行性疾病的健康影响的综合评价。
Molecules. 2020 Aug 21;25(17):3809. doi: 10.3390/molecules25173809.
6
Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral.黄酮类化合物摄入对肥胖的代谢影响:从中枢到外周。
Nutrients. 2020 Aug 10;12(8):2393. doi: 10.3390/nu12082393.

本文引用的文献

1
The Combination of Mulberry Extracts and Silk Amino Acids Alleviated High Fat Diet-Induced Nonalcoholic Hepatic Steatosis by Improving Hepatic Insulin Signaling and Normalizing Gut Microbiome Dysbiosis in Rats.桑椹提取物与丝氨酸的组合通过改善肝脏胰岛素信号和使大鼠肠道微生物群失调正常化,减轻了高脂饮食诱导的非酒精性肝脂肪变性。
Evid Based Complement Alternat Med. 2019 May 30;2019:8063121. doi: 10.1155/2019/8063121. eCollection 2019.
2
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.在超重和肥胖的人类志愿者中补充 Akkermansia muciniphila:概念验证性探索性研究。
Nat Med. 2019 Jul;25(7):1096-1103. doi: 10.1038/s41591-019-0495-2. Epub 2019 Jul 1.
3
Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.鞣花酸通过抑制 AKT/SREBP-1/FASN 通路的从头脂生成来改善 AKT 驱动的小鼠肝脂肪变性。
Food Funct. 2019 Jun 19;10(6):3410-3420. doi: 10.1039/c9fo00284g.
4
Diagnostic and Treatment Implications of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的诊断与治疗意义
Gastroenterol Hepatol (N Y). 2019 Feb;15(2):83-89.
5
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.亚洲地区非酒精性脂肪性肝病的流行率、发病率和结局:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. Epub 2019 Mar 20.
6
Current treatment options for nonalcoholic fatty liver disease.非酒精性脂肪性肝病的当前治疗选择。
Curr Opin Gastroenterol. 2019 May;35(3):168-176. doi: 10.1097/MOG.0000000000000528.
7
Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota.肠道屏障功能-非酒精性脂肪性肝病的相互作用及肠道微生物群的可能作用。
J Agric Food Chem. 2019 Mar 13;67(10):2754-2762. doi: 10.1021/acs.jafc.9b00080. Epub 2019 Mar 4.
8
Cell-specific elevation of Runx2 promotes hepatic infiltration of macrophages by upregulating MCP-1 in high-fat diet-induced mice NAFLD.在高脂饮食诱导的小鼠非酒精性脂肪性肝病(NAFLD)中,Runx2的细胞特异性升高通过上调单核细胞趋化蛋白-1(MCP-1)促进巨噬细胞向肝脏浸润。
J Cell Biochem. 2019 Jul;120(7):11761-11774. doi: 10.1002/jcb.28456. Epub 2019 Feb 11.
9
Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease.肠道微生物衍生介质作为非酒精性脂肪性肝病的潜在标志物。
Biomed Res Int. 2019 Jan 2;2019:8507583. doi: 10.1155/2019/8507583. eCollection 2019.
10
Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features.个性化肠道黏膜定植抵抗经验性益生菌与独特的宿主和微生物组特征相关。
Cell. 2018 Sep 6;174(6):1388-1405.e21. doi: 10.1016/j.cell.2018.08.041.

黑莓叶和果实提取物的混合物可减轻大鼠的非酒精性脂肪变性,增强肠道完整性,并增加(此处原文似乎不完整,缺少具体增加的内容)。

Mixture of blackberry leaf and fruit extracts alleviates non-alcoholic steatosis, enhances intestinal integrity, and increases and in rats.

作者信息

Park Sunmin, Cho Song Mi, Jin Bo Ram, Yang Hye Jeong, Yi Qiu Jing

机构信息

Department of Food and Nutrition, Obesity/Diabetes Center, Hoseo University, Asan 31499, Korea.

Food Functional Research Division, Korean Food Research Institutes, Wanjoo 55365, Korea.

出版信息

Exp Biol Med (Maywood). 2019 Dec;244(18):1629-1641. doi: 10.1177/1535370219889319. Epub 2019 Nov 21.

DOI:10.1177/1535370219889319
PMID:31752528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6963382/
Abstract

UNLABELLED

We hypothesized that a mixture of blackberry fruit and leaf extracts may alleviate non-alcoholic fatty liver disease (NAFLD). Rats with diet-induced NAFLD were used to test the hypothesis and explore possible mechanisms. Male Sprague–Dawley rats were orally administered diets 51% of energy from fat and 450 mg dextrin/kg bw (NAFLD-control), 50% ethanol blackberry leaf extract (450 mg/kg bw; BL), 50% ethanol blackberry fruit extract (450 mg/kg bw; BF), the mixture of blackberry leaf and fruit extracts (2:1; 150 mg/kg bw; BLF), and milk thistle extracts (150 mg/kg bw; positive-control) for 12 weeks. Normal-control rats were fed low-fat diets with 450 mg dextrin/kg bw (20 En% fat diet) Body weight, visceral fat mass, liver triglycerides, serum cholesterol, triglyceride, non-esterified fatty acid, and insulin resistance were all elevated in rats in the NAFLD-control group compared to the normal-controls. Rats in the NAFLD-control group exhibited liver damage accompanied by increased oxidative stress and inflammation compared to the rats in the normal-control group. BL and BLF protected the NAFLD rats against the triglyceride and lipid peroxide accumulation, improved insulin sensitivity and dyslipidemia, and increased the antioxidant enzymes, SOD, and GSH-Px, to levels similar to the normal-control group. Further, BL and BLF ameliorated inflammation and hepatocyte damage compared to the NAFLD-controls, and they suppressed mRNA expressions of genes involved in triglyceride synthesis (FAS and SREBP-1c). BLF also modulated the gut microbiota by elevating and in the feces from the cecum compared to the NAFLD-control group. The integrity of intestinal tissues was improved, and the number of goblet cells was elevated by BLF. In conclusion, BL and BLF prevented high-fat diet-induced liver damage by protecting against oxidation and inflammation-induced injury. BLF (human equivalent 1.3 g/day) might, therefore, be used as a therapeutic agent for NAFLD.

IMPACT STATEMENT

NAFLD is a diet-related metabolic disease with no good drug treatments. Therefore, dietary interventions are needed to alleviate NAFLD. This paper demonstrated that feeding a blackberry leaf and fruit mixture extract can alleviate diet-induced NAFLD in rats. Specifically, the blackberry extract, rich in flavonoids and anthocyanins decreased hepatic triglycerides and lipid peroxides, increased genes related to beta oxidation, decreased those involved fatty acid biosynthesis, alleviated oxidative stress, and suppressed pro-inflammatory cytokine release. The blackberry extract also alleviated gut dysbiosis that was associated with NAFLD by increasing the amount of and in the feces. This research demonstrated that the extract of a common and inexpensive fruit can help alleviate NAFLD and associated intestinal dysbiosis at a dose equivalent to 1.3 g/day in humans. If this work can be duplicated in humans, it would provide a safe and inexpensive intervention to help alleviate NAFLD.

摘要

未标记

我们假设黑莓果实和叶提取物的混合物可能减轻非酒精性脂肪性肝病(NAFLD)。采用饮食诱导的NAFLD大鼠来验证这一假设并探索可能的机制。将雄性斯普拉格-道利大鼠分别口服给予能量51%来自脂肪且含有450mg糊精/kg体重的饮食(NAFLD对照组)、50%乙醇黑莓叶提取物(450mg/kg体重;BL)、50%乙醇黑莓果实提取物(450mg/kg体重;BF)、黑莓叶和果实提取物的混合物(2:1;150mg/kg体重;BLF)以及水飞蓟提取物(150mg/kg体重;阳性对照),持续12周。正常对照组大鼠喂食含有450mg糊精/kg体重的低脂饮食(脂肪含量20%能量的饮食)。与正常对照组相比,NAFLD对照组大鼠的体重、内脏脂肪量、肝脏甘油三酯、血清胆固醇、甘油三酯、非酯化脂肪酸以及胰岛素抵抗均升高。与正常对照组大鼠相比,NAFLD对照组大鼠表现出肝脏损伤,同时伴有氧化应激和炎症增加。BL和BLF保护NAFLD大鼠免受甘油三酯和脂质过氧化物积累的影响,改善胰岛素敏感性和血脂异常,并使抗氧化酶超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px)增加至与正常对照组相似的水平。此外,与NAFLD对照组相比,BL和BLF减轻了炎症和肝细胞损伤,并且它们抑制了参与甘油三酯合成的基因(脂肪酸合酶(FAS)和固醇调节元件结合蛋白1c(SREBP-1c))的mRNA表达。与NAFLD对照组相比,BLF还通过提高盲肠粪便中的 和 来调节肠道微生物群。BLF改善了肠道组织的完整性,并增加了杯状细胞的数量。总之,BL和BLF通过防止氧化和炎症诱导的损伤来预防高脂饮食诱导的肝脏损伤。因此,BLF(人体等效剂量1.3g/天)可能用作NAFLD的治疗药物。

影响声明

NAFLD是一种与饮食相关的代谢疾病,没有良好的药物治疗方法。因此,需要饮食干预来减轻NAFLD。本文证明喂食黑莓叶和果实混合物提取物可减轻大鼠饮食诱导的NAFLD。具体而言,富含黄酮类化合物和花青素的黑莓提取物降低了肝脏甘油三酯和脂质过氧化物,增加了与β氧化相关的基因,减少了参与脂肪酸生物合成的基因,减轻了氧化应激,并抑制了促炎细胞因子的释放。黑莓提取物还通过增加粪便中的 和 量来减轻与NAFLD相关的肠道菌群失调。这项研究表明,一种常见且廉价水果的提取物可以帮助减轻NAFLD以及相关的肠道菌群失调,其剂量相当于人体1.3g/天。如果这项工作能够在人体中重复进行,它将提供一种安全且廉价的干预措施来帮助减轻NAFLD。